广发纳斯达克生物科技人民币(001092)
动态评分： 5.70分
投资组合
| 报告日期 | 代码 | 名称 | 金额(万元) | 比例 |
| 2017-12-31 | FMI | Foundation Medicine Inc | 100.76 | 0.31% |
| 2017-12-31 | IMMU | Immunomedics Inc | 100.1 | 0.31% |
| 2017-12-31 | ANAB | AnaptysBio Inc | 96.42 | 0.3% |
| 2017-12-31 | FOLD | 爱美医疗 | 97.5 | 0.3% |
| 2017-12-31 | HZNP | Horizon Therapeutics plc | 97.5 | 0.3% |
| 2017-12-31 | INSM | Insmed Inc | 97.3 | 0.3% |
| 2017-12-31 | MYGN | 万基遗传 | 96.9 | 0.3% |
| 2017-12-31 | AERI | Aerie Pharmaceuticals Inc | 89.37 | 0.28% |
| 2017-12-31 | CBPO | 泰邦生物 | 88.63 | 0.27% |
| 2017-12-31 | IRWD | Ironwood Pharmaceuticals Inc-A | 82.7 | 0.26% |
| 2017-12-31 | SUPN | Supernus Pharmaceuticals Inc | 83.25 | 0.26% |
| 2017-12-31 | MDCO | 麦迪逊医药 | 81.21 | 0.25% |
| 2017-12-31 | RARE | Ultragenyx Pharmaceutical Inc | 80.49 | 0.25% |
| 2017-12-31 | AIMT | Aimmune Therapeutics Inc | 78.39 | 0.24% |
| 2017-12-31 | ONCE | Spark Therapeutics Inc | 77.55 | 0.24% |
| 2017-12-31 | SPPI | Spectrum Pharmaceuticals Inc | 77.74 | 0.24% |
| 2017-12-31 | XLRN | Acceleron Pharma Inc | 78.23 | 0.24% |
| 2017-12-31 | NVCR | NovoCure Ltd | 73.56 | 0.23% |
| 2017-12-31 | PCRX | Pacira BioSciences Inc | 75.47 | 0.23% |
| 2017-12-31 | ENDP | 远藤制药 | 70.53 | 0.22% |
公告&资料
